Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reith

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|November 1, 1993
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometryA Berner, H E Danielsen, N O Juul, et al.
ACS Chemical Neuroscience|November 2, 2016
Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor AgonistsWei Xu, Xiaozhao Wang, Aaron M Tocker, et al.
Journal of Medicinal Chemistry|March 21, 2003
High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivoSujit K Ghorai, Charles Cook, Matthew Davis, et al.
European Journal of Pharmacology|August 29, 2022
Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640]Aloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
European Journal of Pharmacology|September 27, 2022
Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632]Aloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
European Journal of Pharmacology|September 2, 2019
D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in ratsAloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
Neuropharmacology|January 12, 2019
Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attentionCourtney A Marshall, Zachary D Brodnik, Ole V Mortensen, et al.
Acta Cytologica|February 28, 1998
Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and TutorialM R Melamed, M L Hutchinson, E A Kaufman, et al.
The Science of the Total Environment|June 6, 1994
Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: a Markov model approachM Boysen, A M Downs, J P Rigaut, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|November 1, 1993
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometryA Berner, H E Danielsen, N O Juul, et al.
ACS Chemical Neuroscience|November 2, 2016
Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor AgonistsWei Xu, Xiaozhao Wang, Aaron M Tocker, et al.
Journal of Medicinal Chemistry|March 21, 2003
High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivoSujit K Ghorai, Charles Cook, Matthew Davis, et al.
European Journal of Pharmacology|August 29, 2022
Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640]Aloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
European Journal of Pharmacology|September 27, 2022
Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632]Aloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
European Journal of Pharmacology|September 2, 2019
D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in ratsAloke K Dutta, Soumava Santra, Arman Harutyunyan, et al.
Neuropharmacology|January 12, 2019
Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attentionCourtney A Marshall, Zachary D Brodnik, Ole V Mortensen, et al.
Acta Cytologica|February 28, 1998
Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and TutorialM R Melamed, M L Hutchinson, E A Kaufman, et al.
The Science of the Total Environment|June 6, 1994
Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: a Markov model approachM Boysen, A M Downs, J P Rigaut, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Pageof 24